Table 1 Clinical parameters of CRC patients
| Â | Total (N = 333) |
|---|---|
Age (years, range) | 63 (28–87) |
Sex (male/female) | 209/124 |
BMI (kg/m2, mean ± SD) | 24.3 ± 3.2 |
Smoking (n, %) | 47 (14.1%) |
 Was | 18 (5.4%) |
Drinking (n, %) | 121 (36.3%) |
 Was | 4 (1.2%) |
ASA classification | |
 1 | 110 (33.0%) |
 2 | 198 (59.5%) |
 3 | 25 (7.5%) |
Comorbidity (n, %) | 175 (52.6%) |
 Hypertension | 126 (37.8%) |
 Type 2 diabetes | 69 (20.7%) |
 Pulmonary disease | 23 (6.9%) |
Medication (n, %) | 182 (54.7%) |
 anti-hypertensive | 126 (37.8%) |
 anti-diabetic | 58 (17.4%) |
 anti-inflammatory (nonsteroidal) | 42 (12.6%) |
CEA-high (n, %) | 65 (19.9%) |
Tumor location | |
 Proximal colon | 68 (20.4%) |
 Distal colon | 166 (49.6%) |
 Rectum | 95 (28.5%) |
Tumor stage | |
 0,1 | 76 (22.8%) |
 2 | 102 (30.6%) |
 3 | 108 (32.4%) |
 4 (M1) | 47 (14.1%) |
Lymphatic invasion (n, %) | 98 (29.4%) |
K-ras mutation (n, %) | 101 (33.9%) |
MSI (n, %) | 40 (13.0%) |
 MSS/MSI-L/MSI-H | 267/26/14 |